Intravenous ibuprofen (IVIB; Caldolor®) has been studied extensively in a variety of clinical areas and has emerged as a safe and effective alternative to other nonsteroidal anti-inflammatory drugs. This Special Report evaluates the current data supporting the use of IVIB as a standard of care for the treatment of pain and fever in adult and pediatric patients.